11:06 AM EDT, 04/10/2024 (MT Newswires) -- Dr. Reddy's Laboratories (RDY) said Wednesday that it has launched its drug-free migraine management wearable device Nerivio in Germany through its betapharm subsidiary.

The company said it launched Nerivio in India in 2023 and will launch the device in South Africa later in April and in Spain and the UK in subsequent months.

Nerivio uses remote electrical neuromodulation mechanism for acute and/or prevention migraine treatment for adults and adolescents, Dr. Reddy's said.

Price: 73.15, Change: -0.75, Percent Change: -1.01